| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Harvard Apparatus Regenerative Technology, Inc. (HRGN) has 8 insiders with recent SEC Form 4 filings, including 10 buys and 1 sell. HRGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 280.6K | $420.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2016 | McGorry James Joseph | President And CEO | Buy | 20,000 | $1.07 | $21,400.00 | +24.6% | |
| Jun 13, 2016 | Robinson Thomas H | Director | Buy | 32,000 | $1.17 | $37,475.20 | +177.8% | |
| May 25, 2016 | Canepa John J | Director | Buy | 17,241 | $1.46 | $25,171.86 | New | |
| May 20, 2016 | McNaughton Thomas | Chief Financial Officer | Buy | 5,000 | $1.56 | $7,775.00 | +1.2% | |
| May 20, 2016 | McGorry James Joseph | President And CEO | Buy | 10,000 | $1.56 | $15,600.00 | +14.0% | |
| May 20, 2016 | Kennedy John F | Director | Buy | 6,500 | $1.56 | $10,138.70 | +18.2% | |
| May 19, 2016 | Robinson Thomas H | Director | Buy | 18,000 | $1.36 | $24,400.80 | New | |
| Dec 17, 2015 | Lafrancesca Saverio | Chief Medical Officer | Sell | 2,393 | $1.93 | $4,614.66 | -5.4% | |
| Dec 17, 2015 | Lafrancesca Saverio | Chief Medical Officer | Buy | 2,393 | $2.01 | $4,817.35 | +5.8% | |
| Dec 1, 2015 | Lafrancesca Saverio | Chief Medical Officer | Buy | 10,000 | $3.01 | $30,052.00 | +29.4% |